Skip to main content
. 2014 Aug 6;4(1):6. doi: 10.7603/s40681-014-0006-1

Table 1.

Demographic and clinical characteristics

Demographic characteristics L-PANSS (n=80) H-PANSS (n=9) P value
Age (years) 35 ± 9.3 37 ± 9.6 0.801
Male/Female(male percentage) 2/6 (25%) 4/5 (44%) 0.434
Duration of education (years) 13.0 ± 3.3 11.6 ± 3.6 0.405
Age at illness onset (years) (years) 25.1 ± 7.5 22.3 ± 7.4 0.453
Duration of illness (months) 101.5 ± 71.8 186.7 ± 63.8 0.021 *
Clinical psychiatric condition rating scales
Clinical Global Impression (CGI) 2.9 ± 0.4 3.7 ± 0.5 0.002 **
Quality of life scale (QLS) 63.3 ± 11.4 35.4 ± 14.0 < 0.001**
Hamilton Depression Rating scale 8.1 ± 5.2 12.7 ± 8.4 0.207
Medication amount
Chlorpromazine equivalents 212.5 ± 64.1 237.2 ± 91.0 0.532
Diazepam equivalents 12.5 ± 16.9 5.0 ± 6.1 0.232
Extra-pyramidal symptoms rating scales
Abnormal Involuntary Movement scale 4.1 ± 6.3 5.11 ± 4.5 0.712
Barnes Akathisia Rating scale 0.6 ± 1.2 2.1 ± 2.6 0.162
Simpson-Angus scale 5.8 ± 4.7 7.3 ± 3.5 0.440

All data were expressed as mean value ± standard deviation, except gender.

Low-PANSS (L-PANSS) group included schizophrenics with Positive and Negative Syndrome Scale (PANSS) total score below 65 (median of PANSS total scores of all 17 subjects); High-PANSS (H-PANSS) group included those with PANSS total scores 65 or higher.

*:P<0.05 and **:P<0.01, significance between groups.